Special Issue "Recent Advances in the Discovery and Development of Drugs for Civilization Diseases"
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 940
Special Issue Editors
Interests: molecular modeling; oxidative stress; molecular descriptors; anticoagulants; anticancer drug
Interests: biochemistry; cancer; metabolic diseases; obesity; oxidative stress
Special Issues, Collections and Topics in MDPI journals
Interests: metabolic diseases; organic synthesis; antitumor activity; civilization diseases; bioactive compounds
Special Issue Information
Dear Colleagues,
In the 21st century, the century that makes all dreams come true, medicine will allow us to forget about pain, old age, and diseases. Nothing could be more wrong. Civilization diseases, otherwise known as lifestyle diseases, social diseases, or diseases of the 21st century include non-communicable diseases that spread around the world due to the development of civilization. This phenomenon is accompanied by industrialization, economic development, and, unfortunately, also environmental pollution. We live faster and faster and under more and more stress, we eat incorrectly because we eat on the run, we do not have time to prepare wholesome meals, and we do not have proper eating habits. We do not have enough physical exercise and we smoke cigarettes and abuse alcohol. It turns out that lifestyle diseases are responsible for over 80% of all deaths worldwide. They are responsible for not only shortening the length of life but also the deterioration of its quality. That is why it is so important to counteract them. In order to be able to fight civilization diseases more effectively, proper prevention is needed, with new treatments and drugs. In this Special Issue, we invite potential authors to submit manuscripts in the form of research articles, reviews, or communications that contribute to every aspect of medicinal chemistry, the discovery of new drugs for broadly understood civilization diseases, their synthesis, mechanisms of action, biological activity, and advances in drug dosage forms. This Special Issue will welcome original, high-quality scientific articles, reviews, and communications in the field of computational methods for drug design, i.e., in silico research, as well as synthetic and biochemical approaches in this topic.
Dr. Marcin Gackowski
Dr. Karolina Szewczyk-Golec
Dr. Renata Studzińska
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anticancer drugs
- anticancer treatment
- anticoagulants
- atherosclerosis
- cardiovascular disease
- civilization diseases
- diabetes mellitus
- drug development
- in silico research
- medication form/drug dosage form
- molecular descriptors
- molecular docking
- molecular dynamics
- molecular modeling
- neoplastic disease
- obesity
- QSAR
- radiopharmaceuticals
- synthesis of bioactive compounds
- type 2 diabetes
